Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience
Superinfections with <i>Aspergillus</i> spp. in patients with Coronavirus disease 2019 (CAPA: COVID-19-associated pulmonary aspergillosis) are increasing. Dexamethasone has shown beneficial effects in critically ill COVID-19 patients. Whether dexamethasone increases the risk of CAPA has...
Main Authors: | , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2022-12-01
|
丛编: | Diagnostics |
主题: | |
在线阅读: | https://www.mdpi.com/2075-4418/12/12/3049 |